Showing results (831-840 of 955) with videos related to

Sort By:
Pageof 96
Breast (Edinburgh, Scotland)|November 2, 2019
CinéBreast-factors influencing the time to first metastatic recurrence in breast cancer: Analysis of real-life data from the French ESME MBC databaseP Gougis, M Carton, C Tchokothe, et al.
Journal of Dental Research|March 26, 2013
Common SNPs of AmelogeninX (AMELX) and dental caries susceptibilityB Gasse, S Grabar, A G Lafont, et al.
Molecular Genetics and Metabolism|April 11, 2020
Neonatal factors related to survival and intellectual and developmental outcome of patients with early-onset urea cycle disordersClément Pontoizeau, Célina Roda, Jean-Baptiste Arnoux, et al.
Ebiomedicine|January 11, 2020
Implementation and use of whole exome sequencing for metastatic solid cancerManon Réda, Corentin Richard, Aurelie Bertaut, et al.
BMC Cancer|November 10, 2023
A phase I study of the combination of atezolizumab, tiragolumab, and stereotactic body radiation therapy in patients with metastatic multiorgan cancerNicolas Roussot, Jean-David Fumet, Emeric Limagne, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|September 30, 2017
Late toxicities and clinical outcome at 5 years of the ACCORD 12/0405-PRODIGE 02 trial comparing two neoadjuvant chemoradiotherapy regimens for intermediate-risk rectal cancerD Azria, J Doyen, M Jarlier, et al.
Nature Biomedical Engineering|August 25, 2025
Multiparametric cellular and spatial organization in cancer tissue lesions with a streamlined pipelineMark Buckup, Igor Figueiredo, Giorgio Ioannou, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|October 31, 2012
Clinical outcome of the ACCORD 12/0405 PRODIGE 2 randomized trial in rectal cancerJean-Pierre Gérard, David Azria, Sophie Gourgou-Bourgade, et al.
European Journal of Cancer (Oxford, England : 1990)|August 23, 2012
Predictive factors of positive circumferential resection margin after radiochemotherapy for rectal cancer: the French randomised trial ACCORD12/0405 PRODIGE 2Anne Rullier, Sophie Gourgou-Bourgade, Marta Jarlier, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|April 28, 2025
Second-Line Endocrine Therapy With or Without Palbociclib Rechallenge in Patients With Hormone Receptor-Positive/Human Epidermal Growth Factor Receptor 2-Negative Advanced Breast Cancer: PALMIRA TrialAntonio Llombart-Cussac, Catherine Harper-Wynne, Antonia Perelló, et al.
Pageof 96